Translational Research Cancer Centers Consortium (TRCCC) was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. TRCCC has seen a steady growth in member cancer centers and annual meeting participants over the past decade. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer. The annual TRCCC meeting also provides a unique opportunity for trainees to present and interact in a supportive environment.
Translational Research Cancer Centers Consortium